Cazaly Resources Limited (CAZ.AX)
AUD 0.02
(0.0%)
AUD 0.02
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.14 Million | -773.68 Thousand | -820.3 Thousand | -967.82 Thousand | -1.7 Million | -760.41 Thousand |
| Net Income | -891.45 Thousand | -2.12 Million | -1.74 Million | 716.76 Thousand | 1.71 Million | -1.8 Million |
| Depreciation & Amortization | 278.93 Thousand | 80.04 Thousand | 82.7 Thousand | 77.89 Thousand | 14.39 Thousand | 529.24 Thousand |
| Deferred income taxes | - | -140.67 Thousand | -410.93 Thousand | -306.71 Thousand | -291.96 Thousand | -300.83 Thousand |
| Stock-based compensation | 52.72 Thousand | 29.27 Thousand | 307.61 Thousand | 63.51 Thousand | 255.43 Thousand | 48.01 Thousand |
| Change in working capital | -11.54 Thousand | 48.68 Thousand | 62.08 Thousand | -87.4 Thousand | -7734.00 | 252.82 Thousand |
| Other non-cash items | -572.51 Thousand | 1.33 Million | 878.74 Thousand | -1.43 Million | -3.39 Million | 514.22 Thousand |
| Investing Cash Flow | 489.1 Thousand | -2.82 Million | -1.87 Million | -291.6 Thousand | 19.13 Million | -833.09 Thousand |
| Investments in PPE | -2.2 Million | -3.19 Million | -1.73 Million | -1.68 Million | -961.12 Thousand | -944.93 Thousand |
| Acquisitions | - | -370.93 Thousand | 133.93 Thousand | 934.47 Thousand | 934.47 Thousand | - |
| Investment purchases | -269.14 Thousand | -231.65 Thousand | -960.15 Thousand | -892.13 Thousand | -781.3 Thousand | -8159.00 |
| Sales/Maturities of investments | 2.96 Million | 602.58 Thousand | 826.21 Thousand | 2.22 Million | 17.59 Thousand | - |
| Other Investing Activities | -2.2 Million | 370.93 Thousand | -133.93 Thousand | -874.47 Thousand | 19.92 Million | 120 Thousand |
| Financing Cash Flow | 1.86 Million | - | 767.55 Thousand | 767.55 Thousand | -8.17 Million | 956 Thousand |
| Debt repayment | - | - | - | -8.23 Million | - | -55 Thousand |
| Dividends payments | - | - | - | - | -1.74 Million | - |
| Common Stock Repurchased | -119.33 Thousand | - | - | -7.25 Million | -7.25 Million | -39 Thousand |
| Common Stock Issuance | 1.98 Million | - | 767.55 Thousand | 767.55 Thousand | 821.3 Thousand | 1.01 Million |
| Other Financing Activities | 1.86 Million | - | - | 15.48 Million | 821.3 Thousand | 39 Thousand |
| Accounts receivables | -11.54 Thousand | 47.24 Thousand | 62.08 Thousand | -64.45 Thousand | 11.62 Thousand | 252.82 Thousand |
| Accounts payables | -59.3 Thousand | 1437.00 | - | -22.94 Thousand | -19.35 Thousand | -130.87 Thousand |
| Inventory | - | - | - | - | - | 1.24 Million |
| Other working capital | - | - | - | - | - | -1.11 Million |
| Cash at beginning of period | 3.81 Million | 6.9 Million | 9.59 Million | 10.08 Million | 836.7 Thousand | 1.47 Million |
| Cash at end of period | 5.03 Million | 3.81 Million | 6.9 Million | 9.59 Million | 10.08 Million | 836.7 Thousand |
| Capital Expenditure | -2.2 Million | -3.19 Million | -1.73 Million | -1.68 Million | -961.12 Thousand | -944.93 Thousand |
| Effect of forex changes on cash | - | - | -767.54 Thousand | - | - | - |
| Net cash flow / Change in cash | 1.21 Million | -3.08 Million | -2.69 Million | -491.87 Thousand | 9.24 Million | -637.51 Thousand |
| Free Cash Flow | -3.34 Million | -3.97 Million | -2.55 Million | -2.65 Million | -2.66 Million | -1.7 Million |
| Breakdown | 2024 Q4 | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1 Million | 118.3 Thousand | -2.12 Million | -883.98 Thousand | -1.24 Million | -1.74 Million |
| Depreciation & Amortization | 139.02 Thousand | 139.9 Thousand | 80.04 Thousand | 39.99 Thousand | 40.04 Thousand | 82.7 Thousand |
| Deferred income taxes | - | - | -140.67 Thousand | - | - | -410.93 Thousand |
| Stock-based compensation | - | 52.72 Thousand | 29.27 Thousand | - | 29.27 Thousand | 307.61 Thousand |
| Change in working capital | -11.54 Thousand | - | 48.68 Thousand | 47.24 Thousand | - | 62.08 Thousand |
| Other non-cash items | 464.1 Thousand | -1.03 Million | 1.33 Million | 625.21 Thousand | 806.1 Thousand | 878.74 Thousand |
| Investing Cash Flow | 575.32 Thousand | -86.22 Thousand | -2.82 Million | -993.09 Thousand | -1.83 Million | -1.87 Million |
| Investments in PPE | -619.53 Thousand | -1.58 Million | -3.19 Million | -1.24 Million | -1.95 Million | -1.73 Million |
| Acquisitions | - | -1.49 Million | -370.93 Thousand | - | - | 133.93 Thousand |
| Investment purchases | - | -258.5 Thousand | -231.65 Thousand | -200 Thousand | -31.65 Thousand | -960.15 Thousand |
| Sales/Maturities of investments | 1.19 Million | 1.75 Million | 602.58 Thousand | 449.79 Thousand | 152.79 Thousand | 826.21 Thousand |
| Other Investing Activities | 1.19 Million | 1.49 Million | 370.93 Thousand | -2631.00 | 2631.00 | -133.93 Thousand |
| Financing Cash Flow | -93.99 Thousand | 1.96 Million | - | - | - | 767.55 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -100 Thousand | - | - | - | - | - |
| Common Stock Issuance | -93.99 Thousand | 1.96 Million | - | - | - | 767.55 Thousand |
| Other Financing Activities | 6005.00 | 1.96 Million | - | - | - | - |
| Accounts receivables | -11.54 Thousand | - | 47.24 Thousand | 47.24 Thousand | - | 62.08 Thousand |
| Accounts payables | - | - | 1437.00 | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 4.97 Million | 3.81 Million | 6.9 Million | 4.59 Million | 6.9 Million | 9.59 Million |
| Cash at end of period | 5.03 Million | 4.97 Million | 3.81 Million | 3.81 Million | 4.59 Million | 6.9 Million |
| Capital Expenditure | -619.53 Thousand | -1.58 Million | -3.19 Million | -1.24 Million | -1.95 Million | -1.73 Million |
| Effect of forex changes on cash | - | 3.81 Million | - | - | - | -767.54 Thousand |
| Net cash flow / Change in cash | 63.15 Thousand | 1.15 Million | -3.08 Million | -772.3 Thousand | -2.31 Million | -2.69 Million |
| Free Cash Flow | -1.03 Million | -2.31 Million | -3.97 Million | -1.53 Million | -2.43 Million | -2.55 Million |
ABCA
300707
CLON
NXLLF
PHRMASI
BLTZ